CION Ameerpet
Types & Staging · Reviewed by CION Oncologists · NABH Accredited
Uterine Leiomyosarcoma — A Cancer of the Muscle
This is a different disease from the endometrial cancers described elsewhere on this site, despite sharing an organ. Leiomyosarcoma arises from the muscle wall of the uterus rather than from its lining, and it is a true sarcoma — unlike carcinosarcoma, which despite its name is now understood to be a carcinoma. It is rare, it is aggressive, and it has one characteristic that shapes everything about how it is encountered: it cannot reliably be told apart from an ordinary fibroid before surgery. Many women learn they have it from a pathology report after an operation done for something else entirely.
- Arises from muscle, not lining — a different disease from endometrial cancer
- A true sarcoma — unlike carcinosarcoma, which is not
- Cannot be diagnosed before surgery — no scan or biopsy reliably identifies it
- Removal intact matters — which is why morcellation is restricted
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
How It Differs From Endometrial Cancer
The differences are fundamental rather than incidental, and they explain why almost everything about its management is different.
| Feature | How leiomyosarcoma differs |
|---|---|
| It comes from muscle | Endometrial cancers arise from the lining of the uterus. Leiomyosarcoma arises from the smooth muscle of the wall — the same tissue that forms fibroids. Different cell of origin, different disease. |
| It is a true sarcoma | Unlike carcinosarcoma, which contains sarcoma-like tissue but originates as a carcinoma and is treated as one. The distinction matters because it determines which treatments are used. See carcinosarcoma. |
| It cannot be diagnosed beforehand | No imaging test, blood test or biopsy reliably distinguishes it from a fibroid. An endometrial biopsy samples the lining and will usually be normal, because the tumour is not in the lining. This is the defining practical feature. |
| It spreads through the bloodstream | Rather than principally through lymph nodes, which is how endometrial carcinomas spread. The lungs are the commonest site of distant recurrence, so chest imaging is central to staging and follow-up. |
| Lymph node removal is not routine | Because the spread pattern differs. This is a meaningful difference from the surgery performed for endometrial carcinoma. See lymph nodes. |
| Radiotherapy and chemotherapy have limited established benefit | For disease confined to the uterus and completely removed, evidence that adding treatment improves survival is limited. Surgery is the mainstay, and that is a genuine difference from high-risk endometrial carcinoma. |
| Molecular classification does not apply | The POLE, mismatch repair and p53 grouping is a system for endometrial carcinomas. It is not used here, and its absence from your report is correct rather than an omission. |
It does not develop from a fibroid you have been watching. This is a common and understandable fear. Leiomyosarcoma arises from the same tissue fibroids arise from, but the evidence does not support the idea that benign fibroids turn malignant over time. Having fibroids does not mean you are at meaningful risk of this.
Did You Know? Fibroids are extremely common and leiomyosarcoma is rare, so the overwhelming majority of women having surgery for fibroids have exactly what they think they have. The difficulty is that no scan, no blood test and no preoperative biopsy can reliably tell the two apart — they arise from the same tissue and can look alike on imaging. This is why the way the uterus is removed matters. If a specimen containing an unsuspected sarcoma is cut into fragments inside the abdomen to get it out through small incisions, tumour can be dispersed, and outcomes are worse. That single fact is the reason uncontained power morcellation has been restricted, and it is the most practically useful thing on this page for a woman about to have fibroid surgery. Sources: WHO Classification of Tumours — Female Genital Tumours; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; US Food and Drug Administration safety communications on laparoscopic power morcellation.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Why the Way Surgery Is Done Matters
The most actionable section on this page, and it applies to any woman scheduled for fibroid surgery.
- Morcellation means cutting the specimen up inside the abdomen. It is what allows a large fibroid uterus to be removed through the small incisions used in keyhole surgery, and for genuine fibroids it is entirely reasonable.
- If the specimen contains an unsuspected sarcoma, that disperses it. Tumour fragments scattered within the abdominal cavity are associated with a higher risk of recurrence and with worse survival. This is well documented and it is why the practice changed.
- Contained morcellation or intact removal is preferred. Morcellating inside a retrieval bag, or removing the uterus whole through the vagina or a small incision, avoids the problem. Ask which is planned.
- It matters most after menopause and where imaging is atypical. A new or rapidly growing fibroid after menopause is unusual — fibroids typically shrink once oestrogen falls — and warrants more caution about how surgery is done.
- Ask the question before the operation. “How will the uterus be removed, and will morcellation be used?” is a fair and specific question. It is not a challenge to your surgeon and any good one will answer it directly.
This is not a reason to avoid keyhole surgery for fibroids, which is safe and appropriate for the overwhelming majority of women. It is a reason to have a short conversation about technique beforehand.
Having Fibroid Surgery and Unsure About Technique?
A short conversation about how the uterus will be removed is a reasonable thing to ask for.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Ask How the Uterus Will Be Removed
Contained morcellation or intact removal. It is a fair question and it takes a minute to answer.
If You Have Been Given This Diagnosis
Frequently after an operation done for something else, which is its own kind of shock.
Get the slides reviewed by a sarcoma pathologist
The most important single step. Uterine smooth muscle tumours span a spectrum from ordinary fibroids through unusual variants to frank leiomyosarcoma, and the boundaries are genuinely difficult. Some tumours are reported as being of uncertain malignant potential. Specialist review changes a meaningful proportion of these diagnoses, and it should happen before further treatment is planned.
Ask whether removal was complete and intact
The strongest determinant of outcome, and the first thing a sarcoma team will want to know. If morcellation was used, that changes the discussion and may prompt consideration of further surgery. It is difficult information to receive and it is better known than not.
Chest imaging belongs in the workup
Because leiomyosarcoma spreads through the bloodstream and the lungs are the commonest site of distant recurrence, chest imaging is part of staging and of follow-up in a way it is not for early endometrial carcinoma.
Ask for a sarcoma-experienced opinion
These tumours are rare enough that experience is concentrated in relatively few centres. A gynaecological oncology service with sarcoma input, or a joint discussion with a sarcoma team, is worth seeking rather than assuming your case is straightforward. See choosing a centre.
Question additional treatment carefully
For disease confined to the uterus and completely removed, evidence that adding radiotherapy or chemotherapy improves survival is limited, and treatment carries real costs. Ask what the intent is and what the evidence supports, rather than assuming that more treatment is better. A doctor who declines to add treatment may be practising well.
Want a Sarcoma-Experienced Second Opinion?
Slides reviewed by specialist pathologists and your case discussed with sarcoma input. The opinion is free.
Keeping This in Proportion
Most people reading this page do not have this diagnosis, and some are here because they have fibroids and are frightened.
- Fibroids are extremely common; this is rare. The overwhelming majority of women with fibroids have exactly that, and nothing on this page should change how you think about a fibroid you have been living with.
- Fibroids do not turn into sarcomas. They arise from the same tissue, which is a different statement. The evidence does not support the idea that benign fibroids become malignant over time.
- A rapidly growing fibroid is usually still a fibroid. Growth is a reason for assessment rather than for alarm — but growth after menopause, when fibroids normally shrink, does warrant a proper look.
- Complete removal is the key variable, and it is often achieved. Disease confined to the uterus and taken out intact carries a materially different outlook from disease that was dispersed or had already spread.
- Statistics describe groups, mostly treated years ago. They are averages across all stages and circumstances, not a prediction about any individual. See coping with a diagnosis.
Why Rare Sarcomas Need Specialist Review
The diagnosis sits on a genuinely difficult spectrum, and specialist review changes a meaningful share of these cases.
Slides reviewed, not just the summary line
Tumour board for every diagnosis
Sentinel node mapping where it fits
Decisions for healing, not billing
Costs explained before you commit
Second opinions welcomed, not resented
Take The Next Step
Fibroids Do Not Become Sarcomas
They arise from the same tissue. That is a different statement, and the distinction matters.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Uterine Leiomyosarcoma — Frequently Asked Questions
What is uterine leiomyosarcoma?
It is a rare cancer arising from the smooth muscle of the uterine wall — the same tissue that forms fibroids — rather than from the lining, which is where endometrial cancers begin. It is a true sarcoma, which distinguishes it from carcinosarcoma, a tumour that contains sarcoma-like tissue but originates as a carcinoma and is treated as one. Leiomyosarcoma behaves aggressively and spreads predominantly through the bloodstream rather than through lymph nodes, with the lungs the commonest site of distant recurrence. Complete removal of the intact uterus is the principal determinant of outcome.
Can my fibroid turn into a leiomyosarcoma?
The evidence does not support that. Fibroids and leiomyosarcomas arise from the same tissue, which is not the same as saying one becomes the other, and this distinction is worth holding on to if you have fibroids and have been frightened by something you read. Fibroids are extremely common and leiomyosarcoma is rare, so the overwhelming majority of women with fibroids have exactly what they think they have. Growth in a fibroid is a reason for assessment rather than alarm — though growth after menopause, when fibroids usually shrink, does warrant a proper look.
Why can it not be diagnosed before surgery?
Because no test reliably distinguishes it from a benign fibroid. Ultrasound and MRI can raise suspicion where features are unusual, but they cannot exclude it, and there is no blood test that does. An endometrial biopsy — the standard test for abnormal bleeding — samples the lining of the uterus and will usually be normal, because this tumour is in the muscle wall rather than the lining. As a result, a proportion of leiomyosarcomas are identified only when a pathologist examines a uterus removed for what everyone believed were fibroids.
What is morcellation and why does it matter?
Morcellation is cutting the uterus or a fibroid into smaller pieces inside the abdomen so it can be removed through the small incisions used in keyhole surgery. For genuine fibroids that is entirely reasonable. The problem arises where the specimen contains an unsuspected sarcoma: fragmenting it disperses tumour within the abdominal cavity, which is associated with a higher risk of recurrence and worse survival. Because no preoperative test reliably excludes sarcoma, uncontained power morcellation has been restricted, and morcellating within a retrieval bag or removing the uterus intact is preferred. Ask which is planned before your operation.
What treatment is given after surgery?
Often none, and that can be surprising. For leiomyosarcoma confined to the uterus and completely removed intact, the evidence that adding radiotherapy or chemotherapy improves survival is limited, and both carry real costs. Surgery is the mainstay. This differs markedly from high-risk endometrial carcinoma, where chemotherapy is frequently central. Follow-up includes chest imaging, because the lungs are the commonest site of recurrence. Where disease is advanced or has recurred, systemic treatment is used. Ask what the intent of any proposed treatment is and what the evidence supports, and seek an opinion from a team with sarcoma experience.
Medical disclaimer: This page provides general information about uterine leiomyosarcoma, reviewed by a CION oncologist. It is not a substitute for individual medical advice. This tumour is rare and diagnostically difficult, and specialist pathology review together with input from a team experienced in sarcoma is recommended. Decisions about surgical technique, including morcellation, should be discussed with your surgeon before any operation for fibroids.